Speeple News Search

Sign Up! | Tags | Domains | Statistics | Options | Advanced Search

Pipex acquires mid-stage RA program

fiercebiotech.com » 2008 » August » 19th » Pipex acquires mid-stage RA program

Tagged: phase ii, rheumatoid arthritis, pipex, clinical trial news, nicholas stergis

Pipex Pharmaceuticals has acquired oral dnaJP1, a once-daily candidate for the treatment of rheumatoid arthritis which has completed a 160 patient Phase II clinical trial for the treatment of rheumatoid arthritis. "Oral dnaJP1 certainly complements our existing clinical stage immunology programs which include TRIMESTA, our oral phase II/III clinical program in multiple sclerosis and our CD4 … Continue Reading »

Latest news from :

  1. J&J, Vanderbilt ink rich partnering deal
  2. Array biopharma cuts staff, seeks partnerships
  3. Merck, Galapagos ink $233M obesity deal
  4. Orexigen Phase III obesity drug meets endpoints
  5. Alnylam, Cubist form RNAi partnership

Latest news from fiercebiotech.com:

  1. India drawing more clinical trials
  2. Crucell shares soar on Wyeth merger talks
  3. Plexxikon, Roche ink $335M development pact
  4. Onyx forges $550M pact for S*Bio programs
  5. Satori gains $22M to push Alzheimer's work